Akseera takes on the onus of developing a pharmaceutically sound product, not limited by regulatory and political uncertainty, which are presently faced by the growers who supply marijuana to licensed patients.

Akseera aspires to be the first company in the world to manufacture and launch cost-effective and high quality Cannabis based pharmaceutical products in India through strategic alliances with the Nanomedicine Research Group at Institute of Chemical Technology (ICT), Mumbai; Department of Biomedical Physiology and Kinesiology at Simon Fraser University (SFU), Vancouver;  and Sterkem Pharma Pvt. Ltd.

While ensuring high quality to meet the standards of international health authorities, operations in India Akseera products will have the advantage of lower costs to market and cost-effective manufacturing.

Institute of Chemical Technology, India (is a premier chemical engineering research university in India) and is rated as a top university in India for research in chemical engineering and technology. Akseera Pharma is working with the Nanomedicine Research Group to create the first Pharmaceutical grade Cannabis based medication in India.

Simon Fraser University (SFU), established 1965, has become Canada’s leading comprehensive university with vibrant campuses in British Columbia’s largest municipalities — Vancouver, Burnaby and Surrey — and deep roots in partner communities throughout the province and around the world. Akseera Pharma is working with Prof. Ruben at Department of Biomedical Physiology and Kinesiology.

Sterkem Pharma group of companies, India (established 1974), has a history of marketing and manufacturing quality pharmaceuticals for over four decades and specializes in pain management products.